Multiple Hepatic Epithelioid Hemangioendothelioma; A Rare Case Report

Sami S. Omar

Rizgary Oncology Center, Peshawa Qazi Street, Erbil, Kurdistan, Iraq.

Basak Barzngy

Rizgary Oncology Center, Peshawa Qazi Street, Erbil, Kurdistan, Iraq.

Sawen Dizay

Rizgary Teaching Hospital, Peshawa Qazi Street, Erbil, Kurdistan, Iraq.

Tamara A. Almufty

Maternity Teaching Hospital, Shorish street, erbil, Iraq.

Fairuz A. Kakasur

Rizgary Teaching Hospital, Peshawa Qazi Street, Erbil, Kurdistan, Iraq.

Savan Saeed

Hawler Medical University, College of Medicine, Khanzad Street, Erbil, Iraq.

DOI: https://doi.org/10.61706/MECOJ160131

Keywords: Epithelioid Hemangioendothelioma, Multiple Liver Masses, Vascular Tumor

---

Abstract

Introduction: Epithelioid hemangioendothelioma (EHE) is a very rare vascular tumor. It is characteristically locally aggressive and can arise from soft tissue and bone. There is diagnostic confusion between EHE and other benign and malignant vascular tumors. A WWTR1-CAMTA1 translocation fusion gene is found in 90% of conventional EHE. 

Case Report : A 44-year-old woman was found to have two hepatic lesions after evaluation for right-sided hypochondrial pain. Biopsy of the largest lesion was found to be EHE. Immunohistochemistry showed positivity of tumor cells for CD31 & CD34. A staging CT scan and PET scan were performed and both ruled out other lesions elsewhere in the body. A right hepatectomy was performed. Three lesions were found. All were EHE. The first nodule was found near the portal vein and measured 3x2.6x2cm. The second and third nodules were 1.5x1.5cm and 8mm respectively. After surgery, the patient is under regular follow-up and monitoring. She is still free from any recurrence. 

Discussion : Multiple hepatic epithelioid hemangioendothelioma (EHE) is a diagnostic challenge when there is still a lack of appropriate active and reproducible treatment options for it.  Studies show that most EHE present with multiple liver masses. The definitive diagnosis of EHE is based on histopathology ranging from paucicellular to moderately cellular lesions. On FDG-PET scans, EHE typically show moderate FDG activity. The diagnosis of our case was challenging due to the presence of an occult mass that was not detectable on any imaging modality. Both liver transplantation and liver resection have been discussed; the latter strategy was used in our case.

Conclusion: EHE is a very rare vascular tumor that arises from the cells lining the blood vessels. EHE is a locally aggressive tumor. Hepatic EHE usually presents as multiple masses in the liver. It has its own immunohistochemical and genetic characteristics. Surgery is the mainstay of treatment.

---

References

Amin, S., Chung, H., & Jha, R. (2011). Hepatic epithelioid hemangioendothelioma: MR imaging findings. Abdominal Imaging, 36(4), 407–414. https://doi.org/10.1007/s00261-010-9662-0 DOI: https://doi.org/10.1007/s00261-010-9662-0

Antonescu, C. R., Le Loarer, F., Mosquera, J., Sboner, A., Zhang, L., Chen, C., Chen, H., Pathan, N., Krausz, T., Dickson, B. C., Weinreb, I., Rubin, M. A., Hameed, M., & Fletcher, C. D. M. (2013). Novel YAP1‐TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes, Chromosomes and Cancer, 52(8), 775–784. https://doi.org/10.1002/gcc.22073 DOI: https://doi.org/10.1002/gcc.22073

Bachmann, R., Genin, B., Bugmann, P., Belli, D., Hanquinet, S., Liniger, P., & Le Coultre, C. (2003). Selective Hepatic Artery Ligation for Hepatic Haemangioendothelioma: Case Report and Review of the Literature. European Journal of Pediatric Surgery, 13(4), 280–284. https://doi.org/10.1055/s-2003-42245 DOI: https://doi.org/10.1055/s-2003-42245

Dong, A., Dong, H., Wang, Y., Gong, J., Lu, J., & Zuo, C. (2013). MRI and FDG PET/CT Findings of Hepatic Epithelioid Hemangioendothelioma. Clinical Nuclear Medicine, 38(2), e66–e73. https://doi.org/10.1097/RLU.0b013e318266ceca DOI: https://doi.org/10.1097/RLU.0b013e318266ceca

Epelboym, Y., Engelkemier, D. R., Thomas-Chausse, F., Alomari, A. I., Al-Ibraheemi, A., Trenor, C. C., Adams, D. M., & Chaudry, G. (2019). Imaging findings in epithelioid hemangioendothelioma. Clinical Imaging, 58, 59–65. https://doi.org/10.1016/j.clinimag.2019.06.002 DOI: https://doi.org/10.1016/j.clinimag.2019.06.002

Errani, C., Zhang, L., Sung, Y. S., Hajdu, M., Singer, S., Maki, R. G., Healey, J. H., & Antonescu, C. R. (2011). A novel WWTR1‐CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes, Chromosomes and Cancer, 50(8), 644–653. https://doi.org/10.1002/gcc.20886 DOI: https://doi.org/10.1002/gcc.20886

Fan, Y., Tang, H., Zhou, J., Fang, Q., Li, S., Kou, K., & Lv, G. (2020). Fast-growing epithelioid hemangioendothelioma of the liver. Medicine, 99(36), e22077. https://doi.org/10.1097/MD.0000000000022077 DOI: https://doi.org/10.1097/MD.0000000000022077

Flucke, U., Vogels, R. J., de Saint Aubain Somerhausen, N., Creytens, D. H., Riedl, R. G., van Gorp, J. M., Milne, A. N., Huysentruyt, C. J., Verdijk, M. A., van Asseldonk, M. M., Suurmeijer, A. J., Bras, J., Palmedo, G., Groenen, P. J., & Mentzel, T. (2014). Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases. Diagnostic Pathology, 9(1), 131. https://doi.org/10.1186/1746-1596-9-131 DOI: https://doi.org/10.1186/1746-1596-9-131

Frezza, A. M., Ravi, V., Lo Vullo, S., Vincenzi, B., Tolomeo, F., Chen, T. W., Teterycz, P., Baldi, G. G., Italiano, A., Penel, N., Brunello, A., Duffaud, F., Hindi, N., Iwata, S., Smrke, A., Fedenko, A., Gelderblom, H., Van Der Graaf, W., Vozy, A., … Stacchiotti, S. (2021). Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature. Cancer Medicine, 10(8), 2645–2659. https://doi.org/10.1002/cam4.3807 DOI: https://doi.org/10.1002/cam4.3807

Frota Lima, L. M., Packard, A. T., & Broski, S. M. (2021). Epithelioid hemangioendothelioma: evaluation by 18F-FDG PET/CT. American Journal of Nuclear Medicine and Molecular Imaging, 11(2), 77–86.

Huang, W., Li, L., Gao, J., & Gao, J.-B. (2021). Epithelioid hemangioendothelioma of the right atrium invaded the superior vena cava: case report and review of literature. The International Journal of Cardiovascular Imaging, 37(1), 285–290. https://doi.org/10.1007/s10554-020-01963-w DOI: https://doi.org/10.1007/s10554-020-01963-w

Ishak, K. G., Sesterhenn, I. A., Goodman, M. Z. D., Rabin, L., & Stromeyer, F. W. (1984). Epithelioid hemangioendothelioma of the liver: A clinicopathologic and follow-up study of 32 cases. Human Pathology, 15(9), 839–852. https://doi.org/10.1016/S0046-8177(84)80145-8 DOI: https://doi.org/10.1016/S0046-8177(84)80145-8

Jurczyk, M., Zhu, B., Laskin, W., & Lin, X. (2014). Pitfalls in the diagnosis of hepatic epithelioid hemangioendothelioma by FNA and needle core biopsy. Diagnostic Cytopathology, 42(6), 516–520. https://doi.org/10.1002/dc.22943 DOI: https://doi.org/10.1002/dc.22943

Kallen, M. E., & Hornick, J. L. (2021). The 2020 WHO Classification. American Journal of Surgical Pathology, 45(1), e1–e23. https://doi.org/10.1097/PAS.0000000000001552 DOI: https://doi.org/10.1097/PAS.0000000000001552

Kaltenmeier, C., Stacchiotti, S., Gronchi, A., Sapisochin, G., Liu, H., Ashwat, E., Gunabushanam, V., Reddy, D., Thompson, A., Geller, D., Tohme, S., Zureikat, A., & Molinari, M. (2022). Treatment modalities and long-term outcomes of hepatic hemangioendothelioma in the United States. HPB, 24(10), 1688–1696. https://doi.org/10.1016/j.hpb.2022.03.013 DOI: https://doi.org/10.1016/j.hpb.2022.03.013

Kamarajah, S. K., Robinson, D., Littler, P., & White, S. A. (2018). Small, incidental hepatic epithelioid haemangioendothelioma the role of ablative therapy in borderline patients. Journal of Surgical Case Reports, 2018(8). https://doi.org/10.1093/jscr/rjy223 DOI: https://doi.org/10.1093/jscr/rjy223

Kehagias, D. T., Moulopoulos, L. A., Antoniou, A., Psychogios, V., Vourtsi, A., & Vlahos, L. J. (2000). Hepatic epithelioid hemangioendothelioma: MR imaging findings. Hepato-Gastroenterology, 47(36), 1711–1713.

Kou, K., Chen, Y.-G., Zhou, J.-P., Sun, X.-D., Sun, D.-W., Li, S.-X., & Lv, G.-Y. (2020). Hepatic epithelioid hemangioendothelioma: Update on diagnosis and therapy. World Journal of Clinical Cases, 8(18), 3978–3987. https://doi.org/10.12998/wjcc.v8.i18.3978 DOI: https://doi.org/10.12998/wjcc.v8.i18.3978

Lau, K., Massad, M., Pollak, C., Rubin, C., Yeh, J., Wang, J., Edelman, G., Yeh, J., Prasad, S., & Weinberg, G. (2011). Clinical Patterns and Outcome in Epithelioid Hemangioendothelioma With or Without Pulmonary Involvement. Chest, 140(5), 1312–1318. https://doi.org/10.1378/chest.11-0039 DOI: https://doi.org/10.1378/chest.11-0039

Lin, J., & Ji, Y. (2010). CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma. Hepatobiliary & Pancreatic Diseases International : HBPD INT, 9(2), 154–158.

Liu, Z., & He, S. (2022). Epithelioid Hemangioendothelioma: Incidence, Mortality, Prognostic Factors, and Survival Analysis Using the Surveillance, Epidemiology, and End Results Database. Journal of Oncology, 2022, 1–10. https://doi.org/10.1155/2022/2349991 DOI: https://doi.org/10.1155/2022/2349991

Lyburn, I. D., Torreggiani, W. C., Harris, A. C., Zwirewich, C. V., Buckley, A. R., Davis, J. E., Chung, S. W., Scudamore, C. H., & Ho, S. G. F. (2003). Hepatic Epithelioid Hemangioendothelioma: Sonographic, CT, and MR Imaging Appearances. American Journal of Roentgenology, 180(5), 1359–1364. https://doi.org/10.2214/ajr.180.5.1801359 DOI: https://doi.org/10.2214/ajr.180.5.1801359

Ma, S., Kanai, R., Pobbati, A. V., Li, S., Che, K., Seavey, C. N., Hallett, A., Burtscher, A., Lamar, J. M., & Rubin, B. P. (2022). The TAZ-CAMTA1 Fusion Protein Promotes Tumorigenesis via Connective Tissue Growth Factor and Ras–MAPK Signaling in Epithelioid Hemangioendothelioma. Clinical Cancer Research, 28(14), 3116–3126. https://doi.org/10.1158/1078-0432.CCR-22-0421 DOI: https://doi.org/10.1158/1078-0432.CCR-22-0421

Makhlouf, H. R., Ishak, K. G., & Goodman, Z. D. (1999). Epithelioid hemangioendothelioma of the liver. Cancer, 85(3), 562–582. https://doi.org/10.1002/(SICI)1097-0142(19990201)85:3<562::AID-CNCR7>3.0.CO;2-T DOI: https://doi.org/10.1002/(SICI)1097-0142(19990201)85:3<562::AID-CNCR7>3.0.CO;2-T

Mentzel, T., Beham, A., Calonje, E., Katenkamp, D., & Fletcher, C. D. M. (1997). Epithelioid Hemangioendothelioma of Skin and Soft Tissues: Clinicopathologic and Immunohistochemical Study of 30 Cases. The American Journal of Surgical Pathology, 21(4), 363–374. https://doi.org/10.1097/00000478-199704000-00001 DOI: https://doi.org/10.1097/00000478-199704000-00001

Nakagawa, N., Takahashi, M., Maeda, K., Fujimura, N., & Yufu, M. (1986). Case report: Adrenal haemangioma coexisting with malignant haemangioendothelioma. Clinical Radiology, 37(1), 97–99. https://doi.org/10.1016/S0009-9260(86)80185-4 DOI: https://doi.org/10.1016/S0009-9260(86)80185-4

O’Connell, J. X., Nielsen, G. P., & Rosenberg, A. E. (2001). Epithelioid Vascular Tumors of Bone: A Review and Proposal of a Classification Scheme. Advances in Anatomic Pathology, 8(2), 74–82. https://doi.org/10.1097/00125480-200103000-00003 DOI: https://doi.org/10.1097/00125480-200103000-00003

Requena, L., & Kutzner, H. (2013). Hemangioendothelioma. Seminars in Diagnostic Pathology, 30(1), 29–44. https://doi.org/10.1053/j.semdp.2012.01.003 DOI: https://doi.org/10.1053/j.semdp.2012.01.003

Sheng, W., Pan, Y., & Wang, J. (2013). Pseudomyogenic Hemangioendothelioma. The American Journal of Dermatopathology, 35(5), 597–600. https://doi.org/10.1097/DAD.0b013e31827c8051 DOI: https://doi.org/10.1097/DAD.0b013e31827c8051

Stacchiotti, S., Simeone, N., Lo Vullo, S., Baldi, G. G., Brunello, A., Vincenzi, B., Palassini, E., Dagrada, G., Collini, P., Morosi, C., Greco, F. G., Sbaraglia, M., Dei Tos, A. P., Mariani, L., Frezza, A. M., & Casali, P. G. (2021). Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case‐series analysis within the Italian Rare Cancer Network. Cancer, 127(4), 569–576. https://doi.org/10.1002/cncr.33247 DOI: https://doi.org/10.1002/cncr.33247

Virarkar, M., Saleh, M., Diab, R., Taggart, M., Bhargava, P., & Bhosale, P. (2020). Hepatic Hemangioendothelioma: An update. World Journal of Gastrointestinal Oncology, 12(3), 248–266. https://doi.org/10.4251/wjgo.v12.i3.248 DOI: https://doi.org/10.4251/wjgo.v12.i3.248

Wenger, D. E., & Wold, L. E. (2000). Malignant vascular lesions of bone: radiologic and pathologic features. Skeletal Radiology, 29(11), 619–631. https://doi.org/10.1007/s002560000261 DOI: https://doi.org/10.1007/s002560000261